Insulin-like growth factor-I inhibits the progression of human U-2 OS osteosarcoma cells towards programmed cell death through interaction with the IGF-I receptor.

Cellular and molecular biology (Noisy-le-Grand, France)

Volumn 46, Issue 1, 2000, Pages 71-77

  Herzlieb, N ^a   Gallaher, B W ^a   Berthold, A ^a   Hille, R ^a   Kiess, W ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; ENZYME INHIBITOR; INTERLEUKIN 1BETA CONVERTING ENZYME; PEPTIDE CHLOROMETHYL KETONE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; ARTICLE; CELL COUNT; CELL CULTURE; CULTURE MEDIUM; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM; OSTEOSARCOMA;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; CASPASE 1; CELL COUNT; CULTURE MEDIA, SERUM-FREE; ENZYME INHIBITORS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; OSTEOSARCOMA; RECEPTOR, IGF TYPE 1; TUMOR CELLS, CULTURED;

EID: 0003482410     PISSN: 01455680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)